ASX:ALAPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals

AROVELLA THERAPEUTICS ORD

$0.071

+$0.001 (+1.43%)

Day Range

$0.070 - $0.072

52 Week Range

$0.068 - $0.125

Volume

1.37M

Avg Volume (10D)

705.26K

Market Cap

$85.71M

Price Chart

Market Statistics

Open$0.070

Previous Close$0.070

Day High$0.072

Day Low$0.070

52 Week High$0.125

52 Week Low$0.068

Valuation

Market Cap85.71M

Shares Outstanding1.21B

Price to Book4.51

Trading Activity

Volume1.37M

Value Traded97.48K

Bid$0.070 × 40,697

Ask$0.071 × 22,756

Performance

1 Day1.43%

5 Day-4.05%

13 Week-6.58%

52 Week-27.55%

YTD-23.66%

Technical Indicators

RSI (14)32.91

50-Day SMA$0.085

200-Day SMA$0.089

Arovella Therapeutics confirms anti-tumour effect of lead drug ALA-101 in treating certain cancers

Arovella Therapeutics (ASX: ALA) has presented new data at the American Association for Cancer Research annual meeting relating to lead drug ALA-101 as a novel ‘off-the-shelf’ therapy to treat CD19-expressing leukemias and lymphomas. The data presented used iNKT (invariant natural killer) cells expressing a chimeric antigen receptor (CAR) which targets the CD19 biomarker. The cells […]

1 min read

Imelda Cotton